Advertisement

Archives of Dermatological Research

, Volume 283, Issue 3, pp 162–166 | Cite as

Inhibitory effect of azelaic acid on neutrophil functions: a possible cause for its efficacy in treating pathogenetically unrelated diseases

  • H. Akamatsu
  • J. Komura
  • Y. Asada
  • Y. Miyachi
  • Y. Niwa
Original Contributions

Summary

It has been shown that acne, hyperpigmentation and lentigo malignant are more or less related pathogenetically to reactive oxygen species (ROS). It has recently been reported that azelaic acid is effective in treating these conditions and that it possesses anti-enzymatic and anti-mitochondrial activity, including cytochrome-P450 reductase and 5α-reductase in microsomal preparations with nicotinamide adenine dinucleotide phosphate (NADPH). We therefore investigated the effects of azelaic acid on human neutrophil functions, such as chemotaxis, phagocytosis and ROS generation. ROS generation in a cell-free system was also assessed. The results revealed that neutrophil chemotaxis and phagocytosis as well as ROS generated in a xanthine — xanthine-oxidase system were not significantly changed in the presence of azelaic acid. However, azelaic acid markedly decreased O 2 and OH generated by neutrophils. It may be concluded that the reported clinical effectiveness of azelaic acid is partly due to its inhibitory action on neutrophil-generated ROS, leading to a reduction both in oxidative tissue injury at sites of inflammation and in melanin formation.

Key words

Azelaic acid Neutrophil functions Free radical generation Acne inflammation Hyperpigmentation 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Asada K, Kiso K, Yoshikawa K (1974) Univalent reduction of molecular oxygen by spinach chloroplasts on illumination. J Biol Chem 249:2175–2181Google Scholar
  2. 2.
    Bladon PR, Burke BM, Cunliffe WJ, Forster RA, Holland KT, King K (1986) Topical azelaic acid and the treatment of acne: a clinical and laboratory comparison with oral tetracycline. Br J Dermatol 114:493–499Google Scholar
  3. 3.
    Bligh EG, Dyer WJ (1959) A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37:911–917Google Scholar
  4. 4.
    Breathnach AS, Robins EJ, Bhasin Y, Ethridge L, Nazzaro-Porro M, Passi S (1986) Observations on cell kinetics and viability of a human melanoma cell line exposed to azelaic acid. Histol Histopathol 1:235–240Google Scholar
  5. 5.
    Burton KP, McCord JM, Ghai G (1984) Myocardial alterations due to free-radical generation. Am J Physiol 247:H776-H783Google Scholar
  6. 6.
    Geier G, Hauschild T, Bauer R, Kreysel W (1986) Der Einflu\ von AzelainsÄure auf das Wachstum von Melanomazellkulturen im Vergleich zu Fibroblastenkulturen. Hautarzt 37:146–148Google Scholar
  7. 7.
    Hu F, Mah K, Teramura JD (1986) Effect of dicarboxylic acids on normal and malignant melanocytes in culture. Br J Dermatol 114:17–26Google Scholar
  8. 8.
    Johnson AR, Erdos G (1977) Metabolism of vasoactive peptides by human endothelial cells in culture. J Clin Invest 59:684–695Google Scholar
  9. 9.
    Johnston RB Jr, Lehmeyer JE (1976) Elaboration of toxic oxygen by-products by neutrophils and a model of immune complex disease. J Clin Invest 57:836–841Google Scholar
  10. 10.
    Kensler TW, Bush DM, Kozumbo WJ (1983) Inhibition of tumor promotion by a biomimetic superoxide dismutase. Science 221:75–77Google Scholar
  11. 11.
    King K, Leeming JP, Holland KT, Cunliffe WJ (1985) The effect of azelaic acid on cutaneous microfiora in vivo and in vitro. J Invest Dermatol 84:438Google Scholar
  12. 12.
    Klebanoff SJ, Rosen H (1978) Ethylene formation by polymorphonuclear leukocytes. J Exp Med 148:490–505Google Scholar
  13. 13.
    Leeming JP, Holland KT, Bojar RA (1986) The in vitro antimicrobial effect of azelaic acid. Br J Dermatol 115:551–556Google Scholar
  14. 14.
    Leibl H, Stingl G, Pehamberger H, Korschan H, Konrad K, Wolff K (1985) Inhibition of DNA synthesis of melanoma cells by azelaic acid. J Invest Dermatol 85:417–422Google Scholar
  15. 15.
    Massey V (1959) The microestimation of succinate and the extinction coefficient of cytochrome c. Biochim Biophys Acta 34:255–256Google Scholar
  16. 16.
    McCord JM, Roy RS (1982) The pathophysiology of superoxide: role in inflammation and ischemia. Can J Physiol Pharmacol 60:1346–1352Google Scholar
  17. 17.
    Mensing H, Remier Hevia C, Schmidt KU (1985) Chemotactic behaviour of melanoma cells in vitro: correlation with plasminogen activator activity and influence of azelaic acid. J Invest Dermatol 84:445Google Scholar
  18. 18.
    Michelson AM (1982) Oxygen radicals. Agents Actions 11 [Suppl]:179–201Google Scholar
  19. 19.
    Miyachi Y, Imamura S, Niwa Y (1986) Anti-oxidant action of metronidazole: a possible mechanism of action in rosacea. Br J Dermatol 114:231–234Google Scholar
  20. 20.
    Miyachi Y, Yoshioka A, Imamura S, Niwa Y (1986) Effect of antibiotics on the generation of reactive oxygen species. J Invest Dermatol 86:449–453Google Scholar
  21. 21.
    Miyachi Y, Yoshioka A, Imamura S, Niwa Y (1987) Anti-inflammatory activities of tetracyclines are partly exerted by their anti-oxidant effect. In: Urabe H, Kimura M, Yamamoto K, Ogawa H (eds) Proceedings of the IVth International Congress of Pediatric Dermatology. University of Tokyo Press, Tokyo, pp 291–294Google Scholar
  22. 22.
    Nazzaro-Porro M (1987) Azelaic acid. J Am Acad Dermatol 17:1033–1041Google Scholar
  23. 23.
    Nazzaro-Porro M, Passi S (1978) Identification of tyrosinase inhibitors in cultures of Pityrosporum. J Invest Dermatol 71:205–208Google Scholar
  24. 24.
    Nazzaro-Porro M, Passi S (1978) Effetto degli acidi di-carbossilici in alcune dermatosi pigmentarie. Gioron Ital Dermatol 113:401–404Google Scholar
  25. 25.
    Nazzaro-Porro M, Passi S, Balus L, Breathnach AS, Martin B, Morpurgo G (1979) Effect of dicarboxylic acids on lentigo maligna. J Invest Dermatol 73:296–305Google Scholar
  26. 26.
    Nazzaro-Porro M, Passi S, Zina G, Bernengo A, Breathnach AS, Morpurgo G (1980) Effect of azelaic acid on human malignant melanoma. Lancet II:1109–1111Google Scholar
  27. 27.
    Nazzaro-Porro M, Passi S, Picardo M, Breathnach AS, Clayton R, Zina G (1983) Beneficial effect of 15% azelaic acid cream on acne vulgaris. Br J Dermatol 109:45–48Google Scholar
  28. 28.
    Nazzaro-Porro M, Passi S, Picardo M, Breathnach AS (1985) Possible mechanism of action of azelaic acid on acne. J Invest Dermatol 84:451Google Scholar
  29. 29.
    Nelson RD, Quie PG, Simmons RL (1977) Chemotaxis under agarose. A new and simple method for measuring chemotaxis and spontaneous migration of human polymorphonuclear leukocytes and monocytes. J Immunol 115:1650–1656Google Scholar
  30. 30.
    Niwa Y, Sohmiya K (1984) Enhanced neutrophilic functions in mucocutaneous lymph node syndrome, with special reference to the possible role of increased oxygen intermediate generation in the pathogenesis of coronary thromboarteritis. J Pediatr 104:56–60Google Scholar
  31. 31.
    Niwa Y, Miyake S, Sakane T, Shingu M, Yokoyama M (1982) Auto-oxidative damage in BehÇet's disease — endothelial cell damage following the elevated oxygen radicals generated by stimulated neutrophils. Clin Exp Immunol 49:247–255Google Scholar
  32. 32.
    Niwa Y, Sakane T, Shingu M, Yokoyama MM (1983) Effect of stimulated neutrophils from the synovial fluid of patients with rheumatoid arthritis on lymphocytes — a possible role of increased oxygen radicals generated by the neutrophils. J Clin Immunol 3:228–240Google Scholar
  33. 33.
    Niwa Y, Sakane T, Shingu M, Yanagida I, Komura J, Miyachi Y (1985) Neutrophil-generated active oxygens in linear IgA bullous dermatosis. Arch Dermatol 121:73–78Google Scholar
  34. 34.
    Niwa Y, Kasama T, Miyachi Y, Kanoh T (1989) Neutrophil chemotaxis, phagocytosis and parameters of reactive oxygen species in human aging:cross-sectional and longitudinal studies. Life Sci 44:1655–1664Google Scholar
  35. 35.
    Nordenson I, Beckman G, Beckman L (1976) The effect of superoxide dismutase and catalase on radiation-induced chromosome breaks. Hereditas 82:125–126Google Scholar
  36. 36.
    Passi S, Picardo M, Nazzaro-Porro M, Breathnach AS, Confaloni AM, Serlupi-Crescenzi G (1984) Antimitochondrial effect of saturated medium chain length (C8 to C13) dicarboxylic acids. Biochem Pharmacol 33:103–108Google Scholar
  37. 37.
    Pathak MA, Carraro C (1987) Reactive oxygen species in cutaneous photosensitivity reactions in porphyrias and PUVA photochemotherapy and in melanin pigmentation. In: Hayaishi O, Imamura S, Miyachi Y (eds) The biological role of reactive oxygen species in skin. University of Tokyo Press, Tokyo, pp 75–94Google Scholar
  38. 38.
    Pathak MA, Joshi PC (1984) Production of reactive oxygen species (1O2, O2) by psoralens and ultraviolet radiation (320–440 nm). Biochim Biophys Acta 798:115–126Google Scholar
  39. 39.
    Pathak MA, Ciganek ER, Wick M, Sober AJ, Farinelli WA, Fitzpatrick TB (1985) An evaluation of the effectiveness of azelaic acid as depigmenting and chemotherapeutic agent. J Invest Dermatol 85:222–228Google Scholar
  40. 40.
    Pehamberger H (1984) Das maligne Melanom der Haut, Prognose und Therapie. W. Zuckschwerdt Verlag, Vienna, pp 46–52Google Scholar
  41. 41.
    Picardo M, Passi S, Sirianni MC, Fiorilli M, Russo GD, Cortesi E, Barile G, Breathnach AS, Nazzaro-Porro M (1985) Activity of azelaic acid on cultures of lymphoma- and leukaemia-derived cell lines, normal resting and stimulated lymphocytes, and 3T3 fibroblasts. Biochem Pharmacol 34:1653–1658Google Scholar
  42. 42.
    Rach P, Töpert M (1986) Pharmacologic investigation of azelaic acid. J Invest Dermatol 86:327Google Scholar
  43. 43.
    Robins EJ, Breathnach AS, Ward BJ, Bhasin Y, Ethridge L, Nazzaro-Porro M, Passi S, Picardo M (1985) Effect of dicarboxylic acids on Harding-Passey and Claudman S91 melanoma cells in tissue culture. J Invest Dermatol 85:216–221Google Scholar
  44. 44.
    Root RK, Metcalf JA (1972) H2O2 release from human granulocytes during phagocytosis. J Clin Invest 60:1266–1279Google Scholar
  45. 45.
    Sasaguri Y, Morimatsu M, Kanoshita T, Nakashima T, Inagaki T, Yagi K (1985) Difference in susceptibility to injury by linoleic acid hydroperoxide between endothelial and smooth muscle cells of arteries. J Appl Biochem 7:70–78Google Scholar
  46. 46.
    Schallreuter KU, Wood JM (1989) Free radical reduction in the human epidermis. Free Radic Biol Med 6:519–532Google Scholar
  47. 47.
    Skosey JL, Damgaard E, Chow DC, Sorensen LB (1974) Modification of zymosan-induced release of lysosomal enzymes from polymorphonuclear leukocytes by cytochalasin B. J Cell Biol 62:625–634Google Scholar
  48. 48.
    Stossel TP (1973) Evaluation of opsonic and leukocyte function with a spectrophotometric test in patients with infection and with phagocytic disorders. Blood 42:121–130Google Scholar
  49. 49.
    Yagi K (1984) Increased serum lipid peroxides initiate atherogenesis. Bio Essays 1:58–60Google Scholar
  50. 50.
    Zigler JS Jr, Bodaness RS, Gery I, Kinoshita JH (1983) Effects of lipid peroxidation products on the rat lens in organ culture: a possible mechanism of cataract initiation in retinal degenerative disease. Arch Biochem Biophys 225:149–156Google Scholar

Copyright information

© Springer-Verlag 1991

Authors and Affiliations

  • H. Akamatsu
    • 1
  • J. Komura
    • 1
  • Y. Asada
    • 1
  • Y. Miyachi
    • 2
  • Y. Niwa
    • 1
  1. 1.Department of DermatologyKansai Medical UniversityJapan
  2. 2.Department of Dermatology, Faculty of MedicineKyoto UniversityJapan

Personalised recommendations